Heparin-induced thrombocytopenia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
[[Heparin-associated thrombocytopenia]] | [[Heparin-associated thrombocytopenia]] | ||
[[Heparin-binding EGF-like growth factor]] | |||
==Reference== | ==Reference== |
Revision as of 18:25, 10 December 2011
Heparin-induced thrombocytopenia |
Differentiating Heparin-induced thrombocytopenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Heparin-induced thrombocytopenia On the Web |
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia |
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
Risk calculators and risk factors for Heparin-induced thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Priyamvada Singh, M.B.B.S. [3], Aric C. Hall, M.D., [4]
Overview
Pathophysiology
Epidemiology and Demographics
Causes
Classification
Risk Factors
Differential diagnosis
Diagnosis
History and symptoms
Lab tests
Treatment
Medical therapy
See also
Heparin-associated thrombocytopenia
Heparin-binding EGF-like growth factor